BCL2 and non-small cell lung carcinoma: Our results revealed that LCSE inhibited EGFR activity and protein expression in two NSCLC cells, concomitantly reduced the downstream Akt and Erk-1/-2 signaling, then downregulated Bcl-2, cyclin B1 and cyclin E and elevated Kip1/p27 and Bax.